- Trials with a EudraCT protocol (594)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
594 result(s) found for: Opioid.
Displaying page 9 of 30.
EudraCT Number: 2015-005179-25 | Sponsor Protocol Number: 402-C-326 | Start Date*: 2016-06-10 | |||||||||||
Sponsor Name:Pacira Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block with EXPAREL for Postsurgical Analgesia in Subjects Un... | |||||||||||||
Medical condition: Total Knee Arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002187-24 | Sponsor Protocol Number: D3820C00007 | Start Date*: 2011-11-04 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled 12-Week Extension Study to Assess the Safety and Tolerability of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC) | |||||||||||||
Medical condition: Opioid-induced constipation (OIC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005010-36 | Sponsor Protocol Number: CR-TFB-2013/502 | Start Date*: 2014-01-08 | |||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | |||||||||||||
Full Title: The effect of protracted saphenous nerve and obturator nerve blockade versus saphenous nerve blockade versus local infiltration analgesia in opioid consumption, pain, blockade duration of action an... | |||||||||||||
Medical condition: The medical condition to be examined in this study is the first postoperative period after total knee replacement with a view to pain management. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004920-40 | Sponsor Protocol Number: AFFECT | Start Date*: 2021-03-22 |
Sponsor Name:Vestre Viken HF | ||
Full Title: Affective effects of pre-surgery opioids (AFFECT): a randomized double-blind controlled trial | ||
Medical condition: Healthy adult surgery patients. Health status ASA1 or ASA2 as categorised by a medical doctor at the hospital based on medical history, physical examination. The American Society of Anesthesiologis... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000242-17 | Sponsor Protocol Number: Protocol_PPB_TKA_14012021 | Start Date*: 2021-03-12 | |||||||||||
Sponsor Name:Region Hospital Silkeborg | |||||||||||||
Full Title: The effect of the popliteal plexus block on postoperative opioid consumption, pain, muscle strength and mobilization after total knee arthroplasty - a randomized, controlled, blinded study | |||||||||||||
Medical condition: Postoperative pain following a total knee arthroplasty surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000107-36 | Sponsor Protocol Number: VER-CLBP-001 | Start Date*: 2021-03-24 |
Sponsor Name:Vertanical GmbH | ||
Full Title: Proof of efficacy, maintenance of efficacy, long-term safety and investigation of the potential for dependence and abuse and the effect of abrupt drug withdrawal of VER-01 in a multicenter study in... | ||
Medical condition: For the treatment of patients with chronic non-specific low back pain when drug treatment is indicated and previous optimised treatments with non-opioid analgesics have not led to sufficient pain r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007690-21 | Sponsor Protocol Number: 42160443PAI2001 | Start Date*: 2009-10-02 | |||||||||||
Sponsor Name:Janssen Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Cancer-Related Pain, Foll... | |||||||||||||
Medical condition: Subjects with inadequately controlled, moderate to severe, chronic, cancer-related pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) ES (Completed) PT (Completed) IT (Completed) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002398-57 | Sponsor Protocol Number: OXN3001 | Start Date*: 2005-11-23 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | |||||||||||||
Full Title: A randomized, double-blind, parallel-group, multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of >= 20 mg/day ... | |||||||||||||
Medical condition: Moderate to severe non-malignant pain that requires around the clock opioid therapy and also have constipation secondary to opioid treatment. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) CZ (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001772-11 | Sponsor Protocol Number: OXN2505 | Start Date*: 2014-01-23 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | |||||||||||||
Full Title: An exploratory, double-blind, double-dummy, randomised, 2-period, crossover, Phase IIa study to assess the influence of oxycodone/naloxone prolonged-release tablets (OXN PR) and oxycodone prolonged... | |||||||||||||
Medical condition: The intended indication is: Chronic severe non malignant pain, requiring opioids. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003245-38 | Sponsor Protocol Number: OFA_GAL_21 | Start Date*: 2022-03-08 |
Sponsor Name:Unai Ortega Mera | ||
Full Title: Randomized clinical trial to compare the efficacy of opioid-free versus traditional balanced anesthesia in laparoscopic colorectal surgery | ||
Medical condition: laparoscopic colorectal surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000854-30 | Sponsor Protocol Number: 3200K1-4000-WW(B2541005) | Start Date*: 2009-02-27 | |||||||||||
Sponsor Name:Salix Pharmaceuticals Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of a Fixed Dose of Subcutaneous Methylnaltrexone in Adults With Advanced Illness and Opioid-Induced Constipation: Efficacy, Safety, and Addition... | |||||||||||||
Medical condition: Opioid-induced constipation in subjects with advanced illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) FR (Completed) FI (Prematurely Ended) DK (Prematurely Ended) PT (Completed) SE (Prematurely Ended) DE (Prematurely Ended) BE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005187-24 | Sponsor Protocol Number: OROS-ANA-3001 | Start Date*: 2005-08-16 | |||||||||||
Sponsor Name:JANSSEN-CILAG | |||||||||||||
Full Title: Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in su... | |||||||||||||
Medical condition: Treatment of chronic non-malignant pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002670-36 | Sponsor Protocol Number: OXN3503 | Start Date*: 2009-01-30 | ||||||||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | ||||||||||||||||||
Full Title: A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate non-inferiority in pain and locomotor function and improvement in symptoms of constipation in subjects with... | ||||||||||||||||||
Medical condition: Pain, locomotor function and improvement in constipation in osteoarthritis patients taking opioids | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) CZ (Completed) HU (Completed) NL (Completed) ES (Completed) AT (Completed) FI (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002440-13 | Sponsor Protocol Number: OMT-Satisfaction | Start Date*: 2015-12-15 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: Treatment satisfaction and self-reported symptoms in patients under opioid maintenance therapy | ||
Medical condition: Opioid maintenance treatment (OMT) is an important factor in the medical care of opioid-dependent patients. Qualified OMT combined with general medical care and psychosocial support is effective in... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001841-24 | Sponsor Protocol Number: C25608/4027/BP/EU | Start Date*: 2008-08-04 | |||||||||||
Sponsor Name:Cephalon France | |||||||||||||
Full Title: A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients | |||||||||||||
Medical condition: Breakthrough Pain (BTP) in cancer patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) NL (Completed) FR (Completed) IE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005315-18 | Sponsor Protocol Number: HMX3501 | Start Date*: 2009-07-21 | ||||||||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | ||||||||||||||||||
Full Title: A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio w... | ||||||||||||||||||
Medical condition: Moderate to severe chronic non-cancer or cancer pain with opioid induced constipation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) FI (Completed) GB (Completed) FR (Completed) NL (Completed) DE (Completed) AT (Completed) BE (Completed) DK (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-003510-15 | Sponsor Protocol Number: OXN3006 (incl. Admin. Change 1) | Start Date*: 2006-03-06 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | |||||||||||||
Full Title: A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of ... | |||||||||||||
Medical condition: Moderate to severe chronic non-malignant pain that requires around-the-clock opioid therapy and also have constipation secondary to opioid treatment. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) DE (Completed) GB (Completed) ES (Completed) CZ (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003275-19 | Sponsor Protocol Number: 402-C-322 | Start Date*: 2013-01-29 | |||||||||||
Sponsor Name:Pacira Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Intercostal Nerve Block with Liposome Bupivacaine in Subjects Undergo... | |||||||||||||
Medical condition: Intercostal Nerve Block for Posterolateral Thoracotomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003752-19 | Sponsor Protocol Number: OXN3401 | Start Date*: 2005-02-01 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co.KG | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo- and Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged-release Tablets in Subjects with ... | |||||||||||||
Medical condition: Moderate to severe chronic pain of low back that requires around-the-clock opioid therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) DK (Completed) SK (Completed) ES (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003498-13 | Sponsor Protocol Number: HIP/FUSION#1 | Start Date*: 2016-03-18 | |||||||||||
Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet | |||||||||||||
Full Title: Surgical anesthesia for elective hip surgery - hemodynamic effect of lumbosacral plexus blockade compared to continuous spinal anesthesia | |||||||||||||
Medical condition: No specific medical condition is investigated. The objective of the investigation is to compare two methods for surgical anesthesia for total hip replacement. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
